CLINICAL_TRIALS
trial_result
· 2019-08-20
Clinical Trial Update: Foxiga Korea Local Phase 4 Study [Phase 4]
Summary
A Phase 4 study update for Foxiga in Korea has completed with posted results, involving Type 2 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2019-08-20